(Q64026775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

autoimmune hemolytic anemia

1 reference

based on heuristic

inferred from title

B-cell chronic lymphocytic leukemia

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Giuseppe Leone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

L Laurenti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Tarnani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

P Chiusolo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

L De Padua

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S Sica

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

19 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1819-21; author reply 1821

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17443222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404703

29 December 2019

exact match

0 references

cites work

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404703

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404703